U S Akarca - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

U S Akarca

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Peptides|January 1, 1994

Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase releaseW J Rossowski, Z F Gu, U S Akarca, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|June 7, 2003

Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western TurkeyM Saruc, N Ozden, N Turkel, et al.

Journal of Chemotherapy (Florence, Italy)|December 6, 2005

Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis BR Y Sertoz, S Erensoy, S Pas, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 1998

Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipientsE Ok, A Unsal, A Celik, et al.

Journal of Viral Hepatitis|November 29, 2014

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world settingR Idilman, F Gunsar, M Koruk, et al.

Infection|October 17, 2002

TT virus infection and genotype distribution in blood donors and a group of patients from TurkeyS Erensoy, A A Sayiner, S Türkoğlu, et al.

Journal of Viral Hepatitis|January 22, 2014

Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg declineP Arends, V Rijckborst, P E Zondervan, et al.

Journal of Viral Hepatitis|September 26, 2015

Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patientsW P Brouwer, M J Sonneveld, Q Xie, et al.

Alimentary Pharmacology & Therapeutics|August 12, 2014

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis BW P Brouwer, M J Sonneveld, F Tabak, et al.

Alimentary Pharmacology & Therapeutics|April 28, 2005

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuationM van Zonneveld, H J Flink, E Verhey, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Peptides|January 1, 1994

Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase releaseW J Rossowski, Z F Gu, U S Akarca, et al.

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|June 7, 2003

Functional dyspepsia: relationship between clinical subgroups and Helicobacter pylori status in Western TurkeyM Saruc, N Ozden, N Turkel, et al.

Journal of Chemotherapy (Florence, Italy)|December 6, 2005

Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis BR Y Sertoz, S Erensoy, S Pas, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 31, 1998

Clinicopathological features of rapidly progressive hepatitis C virus infection in HCV antibody negative renal transplant recipientsE Ok, A Unsal, A Celik, et al.

Journal of Viral Hepatitis|November 29, 2014

Long-term entecavir or tenofovir disoproxil fumarate therapy in treatment-naïve chronic hepatitis B patients in the real-world settingR Idilman, F Gunsar, M Koruk, et al.

Infection|October 17, 2002

TT virus infection and genotype distribution in blood donors and a group of patients from TurkeyS Erensoy, A A Sayiner, S Türkoğlu, et al.

Journal of Viral Hepatitis|January 22, 2014

Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg declineP Arends, V Rijckborst, P E Zondervan, et al.

Journal of Viral Hepatitis|September 26, 2015

Peginterferon add-on results in more HBsAg decline compared to monotherapy in HBeAg-positive chronic hepatitis B patientsW P Brouwer, M J Sonneveld, Q Xie, et al.

Alimentary Pharmacology & Therapeutics|August 12, 2014

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis BW P Brouwer, M J Sonneveld, F Tabak, et al.

Alimentary Pharmacology & Therapeutics|April 28, 2005

The safety of pegylated interferon alpha-2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuationM van Zonneveld, H J Flink, E Verhey, et al.

Pageof 2